TROPION-PanTumor03: Phase 2, multicenter study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients (pts) with advanced/metastatic solid tumors-MedSci.cn

TROPION-PanTumor03: Phase 2, multicenter study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients (pts) with advanced/metastatic solid tumors

Meric-Bernstam, F; Janjigian, Y; Lang, J; Ciombor, KK; Ray-Coquard, I; Oza, A; Yonemori, K; Xu, RH; Zhao, JL; Gajavelli, S; Filant, J; Hovey, T; Oaknin, A

CANCER RESEARCH, 2023; 83 (8):

科室
- - 订阅+
  - 更多科室
工具
服务